Publication | Open Access
Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells
44
Citations
44
References
2016
Year
Tumor BiologyLymphoid NeoplasiaOncologyEpigenetic RegulationMedicineLymphoma CellsHistone Deacetylase InhibitorsCancer Cell BiologyAnti-cancer AgentHsp90•craf InteractionsRadiation OncologyCancer BiologyCell BiologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1